Digital Biomarkers Market: By Products (Watches, Bands, wearable injectors, Textiles), By Application (Drug Discovery and Development, Personalised Medicine, Diagnosis, Others), By End-users (Hospitals, CRO, Research Laboratories, Diagnostic Centers), By Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Digital Biomarkers Market size is valued at USD 1,043.3 million in 2021 and is expected to reach USD 1142.45 million by 2028, at a CAGR of 41.12% during the forecast period 2022-2028. Biomarkers are objective assessments that capture physiological, anatomic, and pathological aspects of an individual in order to understand the person's state and the body's warning signs. Digital biomarkers are measurable behavioural and physiological data collected and assessed using digital devices including wearables, digestibles, implantables, and portables. Digital biomarkers help to provide increased imaging capabilities as well as improved spatial resolution. Stomach aortic aneurysm, aortic analyzation, difficult fringe vein ailment, and carotid conduit sickness are among the services provided by digital biomarkers. Digital biomarkers are physiological and behavioural data that are gathered and measured using digital devices such as portables, wearables, implantables, or digestibles. Typically, the information gathered is utilised to explain, affect, and/or forecast health-related outcomes.  this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Digital Biomarkers Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Digital Biomarkers Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). 

Digital Biomarkers Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

Digital Biomarkers Market

An increase in the use of connected digital devices and health-related mobile applications can be credited to the growth of the digital biomarkers industry. These devices can help with a variety of diagnostic and prognostic assessments in a variety of illness areas, such as mental health, diabetes, neurological diseases, and cardiovascular diseases. The digital biomarkers industry is being boosted by the increasing use of smartphones and the introduction of smartwatches, which aid in tracking physiological parameters of a person's health. The digital biomarkers industry is being propelled forward by technological advancements in mobile phones and digitally connected technology.

Key Features of the Reports

  • Global Digital Biomarkers Market expanding at significant CAGR over 2022 to 2028 owing to growing demand for detergents globally
  • Based on form, Product segment accounted for larger market revenue share in 2021 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global sodium silicate market

Digital Biomarkers Market Segmentation

By Product
  • Watches
  • Bands
  • wearable injectors
  • Textiles
By Application
  • Drug Discovery and Development
  • Personalised Medicine
  • Diagnosis
  • Others
By End User
  • Hospitals
  • CRO
  • Research Laboratories
  • Diagnostic Centers

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Market participants:Digital Biomarkers Market  Some of the players in Digital Biomarkers Market
  • The Hague I B.V. (Affymetrix Inc.) (Netherlands)
  • Abbott Laboratories (U.S.)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • AbbVie Inc. (U.S.)
  • Arquer Diagnostics Ltd. (U.K.)
  • Illumina, Inc. (U.S.)
  • Qiagen (Germany)
  • Agilent Technologies (U.S.)
  • Merck & Co. Inc. (U.S.)
  • Becton Dickinson and Company (U.S.)
  • Hologic Inc. (U.S.))